TGFBR2 and breast cancer: Therefore, our results might suggest a context where Tgfβr2 might contribute to malignancy in human TNBC and reveal, for the first time, that a targetable TGFβR signaling pathway is directly activated by BRCA1-deficiency in the induction of EMT in breast cancers.